Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro

T Nakajima1, S Yamamoto, M Cheng

  • 1Laboratory of Immunology, AIDS Research Center, National Institute of Health, Tokyo.

Insights

Soluble interleukin-6 receptor (sIL-6R) is released by myeloma and myelomonocytic cells. This finding suggests sIL-6R could serve as a diagnostic marker for these specific cell types.

Area of Science:

  • Biochemistry
  • Immunology
  • Cell Biology

Background:

  • Interleukin-6 receptor (IL-6R) plays a crucial role in cellular signaling pathways.
  • The existence and release of soluble forms of receptors can impact biological processes.

Purpose of the Study:

  • To investigate the spontaneous release of soluble interleukin-6 receptor (sIL-6R) from human cell lines.
  • To determine if sIL-6R release is specific to certain cell types, particularly myeloma and myelomonocytic cells.
  • To characterize the molecular properties of the released sIL-6R.

Main Methods:

  • Utilized fluorescence sandwich enzyme-linked immunosorbent assay (ELISA) for quantitative measurement of sIL-6R.
  • Employed antibodies specific to IL-6R for assay development.
  • Analyzed the molecular weight of sIL-6R using SDS-PAGE.

Main Results:

  • Soluble IL-6R (sIL-6R) was spontaneously released from the human myeloma cell line U266.
  • sIL-6R was detected in the supernatant of IL-6R-positive cell lines, including myeloma (RPMI8226, PRMI1788) and myelomonocytic (U937, THP-1, HL-60) lines.
  • No sIL-6R release was observed from IL-6R-negative cell lines (Molt-4, Raji).
  • SDS-PAGE indicated the molecular weight of sIL-6R is approximately 50-55 kDa, smaller than the cell surface receptor.

Conclusions:

  • The spontaneous generation of sIL-6R is associated with IL-6R-positive myeloma and myelomonocytic cells.
  • sIL-6R release may serve as a potential biomarker for identifying myeloma and myelomonocytic cells.

Related Concept Videos